Gimme the box and I'll read it myself
should be considered before using GLP-1
Zhang G, Garmey JC, Veldhuis JD
Semaglutide and tirzepatide are GLP-1-based medications originally developed to manage type 2 diabetes
In these cases, the clinical decision involves weighing ongoing symptoms against therapeutic benefitsimproved glycemic control, weight loss, and potential cardiovascular benefits demonstrated in specific medications
Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans, told NBC News the drugs could cause gastroparesis, but the problem could also be caused by another undiagnosed illness or the patients diabetes, and then made worse by the medications